The effect of glucocorticoids on proliferation of human cultured airway smooth muscle

1 Airway smooth muscle proliferation is a significant component of the airway wall remodelling that occurs in asthma. In this study, the effects of glucocorticoids on mitogenic responses of human airway smooth muscle have been examined. 2 Pretreatment of smooth muscle cells with dexamethasone (100 nM, 60 min) inhibited thrombin‐induced increases in [3H]‐thymidine incorporation (DNA synthesis) and cell number. 3 Inhibition of thrombin‐induced [3H]‐thymidine incorporation was also observed with hydrocortisone (0.01‐1 μm) and methylprednisolone (0.001‐0.1 μm) pretreatment. In contrast, pretreatment with either testosterone (0.001‐1 μm), progesterone (0.001‐1 μm), 17β‐oestradiol (0.001‐1 μm), or aldosterone (0.001‐1 μm) had no effect on the response to thrombin. 4 Responses to a range of mitogens including thrombin (0.01–10 u ml−1), epidermal growth factor (EGF, 3–3000 pM), basic fibroblast growth factor (bFGF, 0.3–300 pM) and foetal calf serum (FCS, 0.1–10% v/v) were inhibited by dexamethasone (100 nM) pretreatment. However, the magnitude of the inhibitory effect was dependent on the mitogen, with EGF being the least, and thrombin being the most sensitive to the inhibitory effect. 5 The potency of hydrocortisone as an inhibitor of [3H]‐thymidine incorporation was reduced when FCS (10% v/v, which caused a 40 fold increase in [3H]‐thymidine incorporation) was used as the mitogen in place of thrombin (0.3 u ml−1, which caused a 10 fold increase in [3H]‐thymidine incorporation). 6 The effect of post‐treatment with dexamethasone (100 nM) indicated that addition of the glucocorticoid up to 17–19 h after thrombin (0.3 u ml−1) produced similar degrees of inhibition to those obtained when it was added as a pretreatment. Dexamethasone no longer produced an inhibitory effect if added 21 h or more after the addition of thrombin. 7 These results suggest that glucocorticoids regulate airway smooth muscle proliferation initiated by a range of stimuli. This effect may be of importance in the therapeutic actions of these compounds in asthma, particularly when they are used for prolonged periods of time.

[1]  S. Hossain.  Quantitative measurement of bronchial muscle in men with asthma. , 2015, The American review of respiratory disease.

[2]  A. Stewart,et al.  Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. , 1995, Biochemical pharmacology.

[3]  T. Wilckens.  Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. , 1995, Trends in pharmacological sciences.

[4]  C. Sherr.  G1 phase progression: Cycling on cue , 1994, Cell.

[5]  T. Haahtela,et al.  Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.

[6]  M. Preece,et al.  Endocrine and lung function in asthmatic children on inhaled corticosteroids. , 1994, American journal of respiratory and critical care medicine.

[7]  R. Zitnik,et al.  Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms. , 1994, American journal of respiratory cell and molecular biology.

[8]  D. Shepro,et al.  Arachidonic acid metabolites in bFGF-, PDGF-, and serum-stimulated vascular cell growth. , 1994, Experimental cell research.

[9]  T. Harris,et al.  MITOGENIC ACTIONS OF ENDOTHELIN‐1 AND EPIDERMAL GROWTH FACTOR IN CULTURED AIRWAY SMOOTH MUSCLE , 1994, Clinical and experimental pharmacology & physiology.

[10]  J. Williamson,et al.  G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. , 1994, The Journal of biological chemistry.

[11]  A. Stewart,et al.  Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture , 1994, British journal of pharmacology.

[12]  E. Zelazny,et al.  Interleukin-1β Stimulates the Proliferation of Cultured Airway Smooth Muscle Cells via Platelet-derived Growth Factor , 1993 .

[13]  M. Klagsbrun,et al.  Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. , 1993, The Journal of biological chemistry.

[14]  P. Barnes,et al.  Efficacy and Safety of Inhaled Corticosteroids in Asthma , 1993 .

[15]  A. Brunet,et al.  Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts , 1993, The Journal of cell biology.

[16]  M. Ebina,et al.  Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. , 1993, The American review of respiratory disease.

[17]  J. Pouysségur,et al.  Signaling Pathways of the Thrombin Receptor , 1993, Thrombosis and Haemostasis.

[18]  A. Stewart,et al.  Airway wall remodelling in asthma: a novel target for the development of anti-asthma drugs. , 1993, Trends in pharmacological sciences.

[19]  J. Morley.  Immunopharmacology of asthma. , 1993, Trends in pharmacological sciences.

[20]  E. Ohlstein,et al.  Carvedilol Inhibits Vascular Smooth Muscle Cell Proliferation , 1993, Journal of cardiovascular pharmacology.

[21]  P. Barnes,et al.  Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. , 1992, American journal of respiratory cell and molecular biology.

[22]  J. Nishimura,et al.  Platelet derived growth factor induces c-fos and c-myc mRNA in rat aortic smooth muscle cells in primary culture without elevation of intracellular Ca2+ concentration. , 1992, Biochemical and biophysical research communications.

[23]  M. Grunstein,et al.  Role and mechanism of thromboxane-induced proliferation of cultured airway smooth muscle cells. , 1992, The American journal of physiology.

[24]  C. Twort,et al.  The proliferative response of airway smooth muscle , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  P. Paré,et al.  A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[26]  M. Rattazzi,et al.  Mitogenic effect of lysosomal hydrolases on bovine tracheal myocytes in culture. , 1991, The Journal of clinical investigation.

[27]  J. Chiu,et al.  Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. , 1991, The Journal of biological chemistry.

[28]  R. Panettieri,et al.  Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. , 1990, The American journal of physiology.

[29]  K. Chung,et al.  Mediators of bronchial hyperresponsiveness , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[30]  M. Tanemura,et al.  Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. , 1990, The American review of respiratory disease.

[31]  L. Fabbri,et al.  Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects. , 1987, The Journal of allergy and clinical immunology.

[32]  C. Persson,et al.  Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. , 1986, Acta physiologica Scandinavica.

[33]  H. Sluiter,et al.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. , 1985, The Journal of allergy and clinical immunology.

[34]  M. Badier,et al.  Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. , 1984, The American review of respiratory disease.

[35]  B. Heard,et al.  Hyperplasia of bronchial muscle in chronic bronchitis , 1970, The Journal of pathology.

[36]  P. F. Hansen,et al.  PITUITARY-ADRENAL FUNCTION FOLLOWING HYPOPHYSECTOMY IN MAN. , 1964, Acta endocrinologica.

[37]  A. Stewart,et al.  Regulation of airway wall remodeling: prospects for the development of novel antiasthma drugs. , 1995, Advances in pharmacology.

[38]  J P Landers,et al.  New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. , 1992, Critical reviews in eukaryotic gene expression.

[39]  H. Mehmet,et al.  Regulation of c-fos expression in Swiss 3T3 cells: an interplay of multiple signal transduction pathways. , 1991, British medical bulletin.

[40]  P. Paré,et al.  The mechanics of airway narrowing in asthma. , 1989, The American review of respiratory disease.